COMPANY MILESTONES

Scroll down and enjoy a bit of our company history

COMPANY MILESTONES

Scroll down and enjoy a bit of our company history

2006

Company incorporated; signed first deal.

2007

Opened office in Pretoria; Anita Smal joined as Scientific Affairs Director in Sep 2007.

2008

First applications for registration submitted through our subsidiary, Lasara Traders.

2008

Started consulting for Clicks group to establish Unicorn.

2009

Formed Nucare in partnership with Carecross Health and developed first integrated e-scripting program in RSA.

2009

Own office established in China.

2009

Lasara Traders obtains its licence to manufacture and import medicines from the MCC.

2010

First MA registered (Nebivolol) and licensed to Thebe (Now Ascendis).

2010

E-filing / professional partner of Extedo software solutions for eCTD and pharmacovigilance.

2010

Established JV in Australia/New Zealand and won first tender in ANZ.

2012

One of the first Quetiapine generics launched in South Africa.

2012

Second to market with Sildenafil.

2012

First major tender buyout awarded by DoH.

2014

First eCTD MA approved in South Africa by MCC for a generic medicine (Esomeprazole).

2015

Milestone of more than 100 approved SKUs.

2016

Signed Distribution Agreement with Clicks (Unicorn) Pharmacies.

2016

First biosimilar Enoxaparin approved in EU and licensed out.

2017

Opened office in Cyprus and United Kingdom.

2017

Established ABEX Consumer Division and signed exclusive rights to commercialize Nasaleze in SA.

2006

Company incorporated; signed first deal.

2007

Opened office in Pretoria; Anita Smal joined as Scientific Affairs Director in Sep 2007.

2008

First applications for registration submitted through our subsidiary, Lasara Traders.

2008

Started consulting for Clicks group to establish Unicorn.

2009

Formed Nucare in partnership with Carecross Health and developed first integrated e-scripting program in RSA.

2009

Own office established in China.

2009

Lasara Traders obtains its licence to manufacture and import medicines from the MCC.

2010

First MA registered (Nebivolol) and licensed to Thebe (Now Ascendis).

2010

E-filing / professional partner of Extedo software solutions for eCTD and pharmacovigilance.

2010

Established JV in Australia/New Zealand and won first tender in ANZ.

2012

One of the first Quetiapine generics launched in South Africa.

2012

Second to market with Sildenafil.

2012

First major tender buyout awarded by DoH.

2014

First eCTD MA approved in South Africa by MCC for a generic medicine (Esomeprazole).

2015

Milestone of more than 100 approved SKUs.

2016

Signed Distribution Agreement with Clicks (Unicorn) Pharmacies.

2016

First biosimilar Enoxaparin approved in EU and licensed out.

2017

Opened office in Cyprus and United Kingdom.

2017

Established ABEX Consumer Division and signed exclusive rights to commercialize Nasaleze in SA.